IL0011794802
IL0011794802
Cellebrite DI Ltd.
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 2.83B EUR | 3.66B EUR | 3.44B EUR | 4.48B EUR |
Enterprise Value | 2.42B EUR | 3.54B EUR | 3.33B EUR | 4.38B EUR |
Valuation Multiples | ||||
Trailing P/E | 48.96x | 62.31x | 47.83x | 73.56x |
Forward P/E | 17.24x | -- | -- | -- |
Price to Sales | 5.5x | 7.12x | 6.92x | 12.17x |
Price to Book | 5.25x | 6.8x | 6.73x | 9.25x |
EV/Revenue | 4.71x | 6.89x | 6.7x | 11.9x |
EV/EBITDA | 30.92x | 34.35x | 31.89x | 49.68x |
Price to FCF (P/FCF) | 22.65x | 28.48x | 22.68x | 31.61x |
EV/FCF | 19.41x | 27.56x | 21.95x | 30.89x |
FCF Yield | 4.41% | 3.51% | 4.41% | 3.16% |